Original language | English |
---|---|
Journal | Blood |
Volume | 118 |
Pages (from-to) | 4110 |
ISSN | 0006-4971 |
Publication status | Published - 2011 |
Externally published | Yes |
First interim safety analysis of a phase III randomized trial in a newly diagnosed systemic peripheral T-cell lymphoma trated with CHOP chemotherapy with or without alemtuzumab and consolidated by autologous hematopoietic stem cell transplant.
Francesco Annibale D'Amore, M Gomes da Silva, S Leppa, T Relander, A Pezzutto, GF Lauritzsen, E Weidmann, M Van Gelder, M Merup, H Hagberg, UM Fagerli, Peter De Nully Brown, P Boye Hansen, JM Mariz, M Jankovska, J Walewski, J Doorduijn, A van Hoof, Ilse Christiansen, S Jyrkkiö
Research output: Contribution to journal › Conference abstract in journal › Research › peer-review